C
CVS icon

Cerebellum’s CVS Health CVS Stock Holding History

Cerebellum’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$64K Sell
1,104
-689
-38% -$42.9K 0.3% 119
2020
Q2 		$130K Buy
+1,793
New +$113K 0.09% 108
2019
Q4 		$547K Hold
7,358
– – 0.29% 195
2019
Q3 		$464K Buy
7,358
+1,027
+16% +$60.9K 0.3% 21
2019
Q2 		$345K Buy
6,331
+505
+9% +$27.2K 0.28% 196
2019
Q1 		$314K Buy
5,826
+1,801
+45% +$111K 0.27% 271
2018
Q4 		$264K Buy
+4,025
New +$300K 0.18% 56
2018
Q2 		– Sell
-3,013
Closed -$187K – 436
2018
Q1 		$187K Buy
3,013
+1,220
+68% +$87.5K 0.24% 164
2017
Q4 		$130K Buy
+1,793
New +$130K 0.09% 108

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cerebellum's CVS Position: Q3 2020 in Review

Cerebellum reduced its CVS Health (CVS) stake by 38% in Q3 2020, selling an estimated $42.9K and leaving 1,104 shares worth $64K. The position accounts for 0.3% of the portfolio, ranked #119.

Cerebellum first reported a position in CVS in Q4 2017 and has held it in 9 quarters since. The position peaked at $547K in Q4 2019. 1,815 funds tracked by Wall St. Rank hold CVS as of Q3 2020.

  • Cerebellum held 1,104 shares of CVS Health worth $64K as of Q3 2020.
  • Cerebellum sold 689 CVS Health shares in Q3 2020, an estimated $42.9K.
  • CVS Health made up 0.3% of Cerebellum's portfolio in Q3 2020, its #119 holding.
  • Cerebellum first reported a position in CVS Health in Q4 2017 and has held it in 9 quarters since.
  • Cerebellum's CVS Health position peaked at $547K in Q4 2019.
  • 1,815 funds tracked by Wall St. Rank held CVS Health as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.